A new conference on nanotechnology, sponsored by the Food and Drug Law Institute, will convene February 28-29 at WashingtonDC’s L’Enfant Plaza Hotel and address regulatory and technical issues. Top officials at the agencies responsible for regulating nanotechnology products, including FDA, EPA and OSHA, will discuss their plans for managing and monitoring these products. Food and drug industry representatives and other attendees will learn about international nanotech regulation and the trends in this dynamic field.
The conference is co-sponsored by WoodrowWilsonInternationalCenter for Scholar’s Project on Emerging Nanotechnologies, in partnership with ArizonaStateUniversity and the Burdock Group. Topics include: first and second generation nanotech products already on the market, domestic and international safety and regulations and consumer issues.